Stay updated on MBG453 Combination with Azacitidine Clinical Trial

Sign up to get notified when there's something new on the MBG453 Combination with Azacitidine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MBG453 Combination with Azacitidine Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A new revision v3.4.2 was added to the history, and the previous v3.4.1 entry and its funding notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T10:55:34.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A government funding lapse notice was added and the release version updated to v3.4.1, replacing v3.4.0.
    Difference
    0.2%
    Check dated 2026-02-04T06:26:41.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI updates include showing the glossary, green/red highlights for additions and deletions, and minor wording changes (e.g., 'No FEAR Act data' to 'No FEAR Act Data') with a new revision tag (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T06:08:30.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision 118 (v3.3.4) on 2025-12-18 adds Adverse Events, Participant Flow, References, Contacts/Locations, and Study Status, and the prior Revision v3.3.3 was removed.
    Difference
    0.3%
    Check dated 2026-01-14T02:51:00.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page history now includes a new revision entry Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T13:59:48.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    December 2023 added a termination notice for the sabatolimab program after failures of Phase II/III objectives, not due to safety concerns. 2025-12-12 updates posted Results, Limitations and Caveats, Adverse Events, and Outcome Measures, and related sections; the 2025-06-24 'Results Submitted' entry was removed.
    Difference
    0.3%
    Check dated 2025-12-16T03:23:28.000Z thumbnail image

Stay in the know with updates to MBG453 Combination with Azacitidine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MBG453 Combination with Azacitidine Clinical Trial page.